Literature DB >> 21892650

Multiple risk factors before pediatric cardiac transplantation are associated with increased graft loss.

Scott R Auerbach1, Marc E Richmond, Jonathan M Chen, Ralph S Mosca, Jan M Quaegebeur, Linda J Addonizio, Daphne T Hsu, Jacqueline M Lamour.   

Abstract

Identification of heart transplant recipients at highest risk for a poor outcome could lead to improved posttransplantation survival. A chart review of primary heart transplantations from 1993 to 2006 was performed. Analysis was performed to evaluate the risk of graft loss for those with a transplantation age less than 1 year, congenital heart disease (CHD), elevated pulmonary vascular resistance (index > 6), positive panel reactive antibody or crossmatch, liver or renal dysfunction, mechanical ventilation, or mechanical circulatory support (MCS). Primary transplantation was performed for 189 patients. Among these patients, 37% had CHD, 23% had mechanical ventilation, and 6% had renal dysfunction. Overall graft survival was 82% at 1 year and 68% at 5 years. The univariate risk factors for graft loss included mechanical ventilation (hazard ratio [HR], 1.9; 95% confidence interval [CI], 1.15-3.18), CHD (HR, 1.68; 95% CI, 1.04-2.70), and renal dysfunction (HR, 3.05; 95% CI, 1.34-6.70). The multivariate predictors of graft loss were CHD (HR, 1.8; 95% CI, 1.02-2.64), mechanical ventilation (HR, 1.9; 95% CI, 1.13-3.10), and the presence of two or more statistically significant univariate risk factors (SRF) (HR, 3.8; 95% CI, 2.00-7.32). Mechanical ventilation, CHD, and the presence of two or more SRFs identify pediatric patients at higher risk for graft loss and should be considered in the management of children with end-stage heart failure.

Entities:  

Mesh:

Year:  2011        PMID: 21892650     DOI: 10.1007/s00246-011-0077-7

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  29 in total

1.  Registry of the International Society for Heart and Lung Transplantation: eighth official pediatric report--2005.

Authors:  Mark M Boucek; Leah B Edwards; Berkeley M Keck; Elbert P Trulock; David O Taylor; Marshall I Hertz
Journal:  J Heart Lung Transplant       Date:  2005-08       Impact factor: 10.247

Review 2.  Registry of the International Society for Heart and Lung Transplantation: tenth official pediatric heart transplantation report--2007.

Authors:  Mark M Boucek; Paul Aurora; Leah B Edwards; David O Taylor; Elbert P Trulock; Jason Christie; Fabienne Dobbels; Axel O Rahmel; Berkeley M Keck; Marshall I Hertz
Journal:  J Heart Lung Transplant       Date:  2007-08       Impact factor: 10.247

3.  Outcomes with an alternate list strategy for heart transplantation.

Authors:  G Michael Felker; Carmelo A Milano; Jonathan E E Yager; Adrian F Hernandez; Laura Blue; Michael B Higginbotham; Andrew J Lodge; Stuart D Russell
Journal:  J Heart Lung Transplant       Date:  2005-08-08       Impact factor: 10.247

4.  Alternate waiting list strategies for heart transplantation maximize donor organ utilization.

Authors:  Jonathan M Chen; Mark J Russo; Kim M Hammond; Donna M Mancini; Aftab R Kherani; Jen M Fal; Pamela A Mazzeo; Sean P Pinney; Niloo M Edwards; Yoshifumi Naka
Journal:  Ann Thorac Surg       Date:  2005-07       Impact factor: 4.330

5.  Outcomes of children bridged to heart transplantation with ventricular assist devices: a multi-institutional study.

Authors:  Elizabeth D Blume; David C Naftel; Heather J Bastardi; Brian W Duncan; James K Kirklin; Steven A Webber
Journal:  Circulation       Date:  2006-05-16       Impact factor: 29.690

6.  Use of a continuous-flow device in patients awaiting heart transplantation.

Authors:  Leslie W Miller; Francis D Pagani; Stuart D Russell; Ranjit John; Andrew J Boyle; Keith D Aaronson; John V Conte; Yoshifumi Naka; Donna Mancini; Reynolds M Delgado; Thomas E MacGillivray; David J Farrar; O H Frazier
Journal:  N Engl J Med       Date:  2007-08-30       Impact factor: 91.245

7.  Oversizing of donor hearts: beneficial or detrimental?

Authors:  M R Costanzo-Nordin; Y L Liao; B B Grusk; E J O'Sullivan; R S Cooper; M R Johnson; K M Siebold; H J Sullivan; A H Heroux; J A Robinson
Journal:  J Heart Lung Transplant       Date:  1991 Sep-Oct       Impact factor: 10.247

8.  Cardiac transplant outcomes in pediatric patients with pre-formed anti-human leukocyte antigen antibodies and/or positive retrospective crossmatch.

Authors:  Eric J Wright; William P Fiser; R Erik Edens; Elizabeth A Frazier; W Robert Morrow; Michiaki Imamura; Robert D B Jaquiss
Journal:  J Heart Lung Transplant       Date:  2007-09-27       Impact factor: 10.247

9.  Matching high-risk recipients with marginal donor hearts is a clinically effective strategy.

Authors:  Mark J Russo; Ryan R Davies; Kimberly N Hong; Jonathan M Chen; Michael Argenziano; Alan Moskowitz; Deborah D Ascheim; Isaac George; Allan S Stewart; Mathew Williams; Annetine Gelijns; Yoshifumi Naka
Journal:  Ann Thorac Surg       Date:  2009-04       Impact factor: 4.330

10.  The use of mechanical circulatory support as a bridge to transplantation in pediatric patients: an analysis of the United Network for Organ Sharing database.

Authors:  Ryan R Davies; Mark J Russo; Kimberly N Hong; Michael L O'Byrne; David P Cork; Alan J Moskowitz; Annetine C Gelijns; Seema Mital; Ralph S Mosca; Jonathan M Chen
Journal:  J Thorac Cardiovasc Surg       Date:  2008-02       Impact factor: 5.209

View more
  3 in total

1.  Extracorporeal membrane oxygenation support after pediatric orthotopic heart transplantation.

Authors:  Jennifer A Su; Robert B Kelly; Tristan Grogan; David Elashoff; Juan C Alejos
Journal:  Pediatr Transplant       Date:  2014-10-27

2.  Steroid avoidance in pediatric heart transplantation results in excellent graft survival.

Authors:  Scott R Auerbach; Jane Gralla; David N Campbell; Shelley D Miyamoto; Biagio A Pietra
Journal:  Transplantation       Date:  2014-02-27       Impact factor: 4.939

Review 3.  Peri-operative kidney injury and long-term chronic kidney disease following orthotopic heart transplantation in children.

Authors:  Aparna Hoskote; Michael Burch
Journal:  Pediatr Nephrol       Date:  2014-08-14       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.